Literature DB >> 12542989

Immunopharmacology of hypersensitivity reactions to drugs.

Dean J Naisbitt1, Munir Pirmohamed, B Kevin Park.   

Abstract

Drug hypersensitivity reactions are characterized by their unpredictability, lack of simple dose-dependency, host sensitivity, and potentially serious clinical outcome. They occur in a small proportion of patients, and usually the predisposing factors are unknown, although there is increasing evidence for genetic predisposition and disease being significant risk factors. The current understanding of the chemical basis of immune-mediated reactions is based on the hapten hypothesis, which requires drug bioactivation, covalent binding to proteins, followed by uptake, antigen processing, and a polyclonal immune response. The recently proposed "danger hypothesis" can be considered to be an essential addition to the hapten hypothesis. According to the danger hypothesis, the immune response to a drug-derived antigen requires the presence of co-stimulatory signals and cytokines, which propagate and determine the type of immune response. The "danger signal" might result from chemical, physical, or viral stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12542989     DOI: 10.1007/s11882-003-0006-9

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  47 in total

1.  Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells.

Authors:  J M Curtsinger; C S Schmidt; A Mondino; D C Lins; R M Kedl; M K Jenkins; M F Mescher
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

Review 2.  Idiosyncratic drug reactions: the reactive metabolite syndromes.

Authors:  S R Knowles; J Uetrecht; N H Shear
Journal:  Lancet       Date:  2000-11-04       Impact factor: 79.321

Review 3.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

4.  Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis.

Authors:  Hitoshi Akiba; Jeanne Kehren; Marie-Thérèse Ducluzeau; Maya Krasteva; Françoise Horand; Dominique Kaiserlian; Fumio Kaneko; Jean-François Nicolas
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

5.  Characterization of drug-specific T cells in phenobarbital-induced eruption.

Authors:  Hideo Hashizume; Masahiro Takigawa; Yoshiki Tokura
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

6.  A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.

Authors:  T P Reilly; L H Lash; M A Doll; D W Hein; P M Woster; C K Svensson
Journal:  J Invest Dermatol       Date:  2000-06       Impact factor: 8.551

7.  Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s).

Authors:  S Madden; J L Maggs; B K Park
Journal:  Drug Metab Dispos       Date:  1996-04       Impact factor: 3.922

8.  T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction.

Authors:  B Schnyder; K Frutig; D Mauri-Hellweg; A Limat; N Yawalkar; W J Pichler
Journal:  Clin Exp Allergy       Date:  1998-11       Impact factor: 5.018

9.  Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation.

Authors:  Dean J Naisbitt; John Farrell; S Fraser Gordon; James L Maggs; Christoph Burkhart; Werner J Pichler; Munir Pirmohamed; B Kevin Park
Journal:  Mol Pharmacol       Date:  2002-09       Impact factor: 4.436

10.  CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes.

Authors:  M Hertl; F Jugert; H F Merk
Journal:  Br J Dermatol       Date:  1995-02       Impact factor: 9.302

View more
  12 in total

Review 1.  Hypersensitivity reactions to HIV therapy.

Authors:  Mas Chaponda; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 2.  Genetic factors in the predisposition to drug-induced hypersensitivity reactions.

Authors:  Munir Pirmohamed
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

3.  Quinine-dependent, platelet-reactive monoclonals mimic antibodies found in patients with quinine-induced immune thrombocytopenia.

Authors:  Daniel W Bougie; Jessica Birenbaum; Mark Rasmussen; Mortimer Poncz; Richard H Aster
Journal:  Blood       Date:  2008-10-23       Impact factor: 22.113

Review 4.  Clinical pharmacology: special safety considerations in drug development and pharmacovigilance.

Authors:  Kwame N Atuah; Dyfrig Hughes; Munir Pirmohamed
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  Cutaneous drug hypersensitivity: immunological and genetic perspective.

Authors:  Kisalay Ghosh; Gautam Banerjee; Asok Kumar Ghosal; Jayoti Nandi
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

Review 6.  Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.

Authors:  Kalliopi Gerogianni; Aspasia Tsezou; Konstantinos Dimas
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.476

7.  Clinical factors predicting drug-induced liver injury due to flucloxacillin.

Authors:  Mikaela Lindh; Pär Hallberg; Qun-Ying Yue; Mia Wadelius
Journal:  Drug Healthc Patient Saf       Date:  2018-11-21

8.  The diamine oxidase gene is associated with hypersensitivity response to non-steroidal anti-inflammatory drugs.

Authors:  José A G Agúndez; Pedro Ayuso; José A Cornejo-García; Miguel Blanca; María J Torres; Inmaculada Doña; María Salas; Natalia Blanca-López; Gabriela Canto; Carmen Rondon; Paloma Campo; José J Laguna; Javier Fernández; Carmen Martínez; Elena García-Martín
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

9.  Captopril-induced bilateral parotid and submandibular sialadenitis.

Authors:  Rafael Mariano Gislon Da Silva
Journal:  Eur J Clin Pharmacol       Date:  2004-07-06       Impact factor: 3.064

10.  Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4.

Authors:  Shufeng Zhou; Eli Chan; Xiaotian Li; Min Huang
Journal:  Ther Clin Risk Manag       Date:  2005-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.